Are We Missing Patients? Expanding Germline Genetic Testing in Oncology

As recommendations for germline genetic testing continue to expand, many eligible patients remain untested. In this episode of Cancer Advances, Demitrios Dedousis, MD, discusses current testing indications, common gaps in implementation and the clinical implications of identifying hereditary cancer predisposition syndromes. Learn how germline findings can influence treatment decisions, screening protocols and risk assessment for families.